Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

SIUE School of Pharmacy

New Options for Anti-platelet Therapy

Access Activity

Overview / Abstract:

This program is designed to educate pharmacists on newly available antiplatelet therapies (prasugrel, ticagrelor, and vorpaxar). The program will cover the mechanism of action, dosing, contraindications, significant clinical trials, and clinical pearls of these therapies. Upon completion of this CPE program, participants should be able to differentiate between the new antiplatlet agents, identify contraindications for these medications, and list monitoring parameters for patients taking these therapies.


Dec 04, 2017


Pharmacy CPE





Credits / Hours

1.0 hrs. (0.1 CEUs)



Presenters / Authors / Faculty

Breanna Wyman, Pharm.D.

Cathryn McIntosh, Pharm.D.

Keywords / Search Terms

SIUE School of Pharmacy SIUE School of Pharmacy

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.